
|Articles|December 1, 2004
IVAX markets generic version of Alphagan
IVAX Corp. joins the growing number of drug manufacturers to market its version of brimonidine tartrate ophthalmic solution 0.2%.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
4
AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg
5